No abstract available
MeSH terms
-
Antineoplastic Agents / economics*
-
Antineoplastic Agents / therapeutic use*
-
Cost Savings
-
Cost-Benefit Analysis
-
Drug Costs* / legislation & jurisprudence
-
Health Policy / economics*
-
Health Policy / legislation & jurisprudence
-
Health Services Accessibility / economics
-
Health Services Accessibility / legislation & jurisprudence
-
Healthcare Disparities / economics*
-
Healthcare Disparities / legislation & jurisprudence
-
Humans
-
Neoplasms / diagnosis
-
Neoplasms / drug therapy*
-
Neoplasms / economics*
-
Neoplasms / mortality
-
Treatment Outcome